SEC 13F Intelligence

Jennison Associates LLC / SG7

Jennison Associates LLC’s Sage Therapeutics Inc Position

Does Jennison Associates LLC own Sage Therapeutics Inc (SG7)? Not currently — the last reported position was 582.1K shares worth $33M in Q2 2021; the fund’s latest 13F (Q1 2026) no longer reports it.

Position Value
$33M
Q2 2021
Shares
582.1K
% of Portfolio
+0.02%
Quarters Held
11
position exited

Position History SG7

Reported value by quarter
Q4 ’18: $81MQ4 ’18Q1 ’19: $375MQ2 ’19: $541MQ2 ’19Q3 ’19: $399MQ4 ’19: $31MQ4 ’19Q1 ’20: $6MQ2 ’20: $9MQ2 ’20Q3 ’20: $27MQ4 ’20: $49MQ4 ’20Q1 ’21: $42MQ2 ’21: $33MQ2 ’21filingsflow.com
QuarterSharesValue% of Portfolio
Q2 2021582.1K$33M+0.02%
Q1 2021559.5K$42M+0.03%
Q4 2020564.0K$49M+0.03%
Q3 2020438.4K$27M+0.02%
Q2 2020218.2K$9M+0.01%
Q1 2020217.7K$6M+0.01%
Q4 2019431.2K$31M+0.03%
Q3 20192.84M$399M+0.42%
Q2 20192.95M$541M+0.54%
Q1 20192.36M$375M+0.37%
Q4 2018845.7K$81M+0.09%

Common-stock position only; options are excluded. Quarters where the fund filed no 13F or reported no position are absent. See Jennison Associates LLC’s full portfolio or all institutional holders of SG7.